Pembrolizumab in Early Stage Colon Cancer

NCT04231526 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped unable to accrue

Conditions

Colon Cancer

Interventions

DRUG: Pembrolizumab
PROCEDURE: Surgery

Sponsor

University of Chicago

Collaborators

[object Object]